Home » Topics » Regulatory

Regulatory
RSS

Precedex IV 200 mcg approved for long-term use in Japan

Aug. 23, 2010

FDA approves new docetaxel injection concentrate formulation for cancer

Aug. 6, 2010

FDA accepts NDA for gadobutrol injection in MRI of CNS

Aug. 6, 2010

FDA approves two new dose strengths of niacin/simvastatin

July 29, 2010

FDA approves Cuvposa for chronic drooling in children with neurological disorders

July 29, 2010

FDA approves Daiichi Sankyo's Tribenzor for hypertension

July 27, 2010

FDA approves Aricept 23-mg tablet for Alzheimer's disease

July 26, 2010

Health Canada approves Winston Laboratories' Civanex for osteoarthritis pain

July 21, 2010

Takeda's Lampion pack approved in Japan

July 20, 2010

Botox licensed in U.K. for prophylaxis of chronic migraine

July 12, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...